semaglutide and kidney issues Semaglutides Are Poised to Remake Chronic Disease Care Semaglutide lowers UACR in overweight

Both have FDA considerations worth understanding before deciding

Conversely, some patients may experience fatigue as a side effect, leading to reduced activity and subsequent joint stiffness

Acknowledgments The authors would like to acknowledge the financial support by the Spanish Ministry of Economy and Competitiveness/Health research fund FIS-FEDER (PI13/0047, PI14/00386 and PIE13/00051) and by the Fundacin Renal Iigo Alvarez de Toledo (FRIAT)

Safety and efficacy of an oral insulin (capsulin) in patients with early-stage type 2 diabetes: a dose-ranging phase IIb study

Retatrutide acts on three (adding the glucagon receptor) and is still in trials